Sign In
Buy RCEL
$4.16
-0.0300 (-0.716%)
At Close: Jun 03, 2026
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
09:01am, Wednesday, 10'th Jan 2024
VALENCIA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a commercial-stage regenerative medicine company focused on first-in-class devices
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
09:00am, Thursday, 04'th Jan 2024
VALENCIA, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cell
AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum
08:38pm, Tuesday, 19'th Dec 2023
AVITA Medical's Spray-On Skin Cells device rapidly processes a patient's own skin to treat large dermatological injuries. The company's sales growth is expected to accelerate in 2024 due to the supple
AVITA Medical to Host Investor Webinar Briefing
09:00am, Monday, 04'th Dec 2023
VALENCIA, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of f
Avita (RCEL) Falls 19% on Lowered 2023 Revenue Guidance
09:46am, Wednesday, 22'nd Nov 2023
Avita's (RCEL) stock declines 19% after the company lowered its total revenue guidance for 2023.
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
04:15pm, Tuesday, 21'st Nov 2023
VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of f
AVITA Medical Updates Full Year 2023 Guidance
04:15pm, Monday, 20'th Nov 2023
VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of f
AVITA Medical, Inc. (RCEL) Q3 2023 Earnings Call Transcript
08:39pm, Thursday, 09'th Nov 2023
AVITA Medical, Inc. (NASDAQ:RCEL ) Q3 2023 Results Conference Call November 9, 2023 4:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Offic
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
04:01pm, Thursday, 09'th Nov 2023
VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of f
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
09:00am, Thursday, 09'th Nov 2023
AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations, to strategically expand its global presence to Europe.
AVITA Medical to Announce Third Quarter 2023 Financial Results
04:05pm, Thursday, 19'th Oct 2023
VALENCIA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class device
Why Shares of Avita Medical Are Down Monday
02:37pm, Monday, 02'nd Oct 2023
The FDA is asking for more information regarding Avita's Recell Go device. The Recell Go is a more automated version of an already approved product for Avita.
AVITA Medical to Present at the Cantor Global Healthcare Conference
04:30pm, Thursday, 21'st Sep 2023
VALENCIA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devic
AVITA Medical to Participate in Upcoming Investor Conferences
06:45pm, Wednesday, 06'th Sep 2023
VALENCIA, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devic
AVITA Medical, Inc. (RCEL) Q2 2023 Earnings Call Transcript
10:47pm, Thursday, 10'th Aug 2023
AVITA Medical, Inc. (NASDAQ:RCEL ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Jessica Ekeberg - Investor Relations James Corbett - Chief Executive Officer David O
